✦ LIBER ✦

404 Phase I study of MEDI-575, a fully human monoclonal antibody targeting PDGFR-alpha in subjects with advanced solid tumors

✍ Scribed by R. Lechleider; C. Becerra; M. Liang; R. Narwal; L. Shi; P. Conkling; M. Galsky; R. Jotte; H. Wu; N.J. Vogelzang

Book ID: 119603087
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 47 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)72111-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of olaratumab, an anti-p

A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors

✍ Chiorean, E. Gabriela; Sweeney, Christopher; Youssoufian, Hagop; Qin, Amy; Donta 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 529 KB

Phase I Safety and Pharmacokinetic Study

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

✍ Gerber, D. E.; Stopeck, A. T.; Wong, L.; Rosen, L. S.; Thorpe, P. E.; Shan, J. S 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 346 KB

A phase I study of the human monoclonal

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

29 A First-in-Human Phase I Monotherapy

29 A First-in-Human Phase I Monotherapy Study of RG7212 (R), a Novel Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Solid Tumors

✍ Lassen, U.; Schellens, J.H.M.; Siu, L.L.; Jonker, D.J.; Sorensen, M.; Jarutat, T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

372 A phase I dose-escalation study of t

372 A phase I dose-escalation study of the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously to patients with advanced solid tumors

✍ C. Weekes; P. Hedge; Y. Xin; R. Yu; H. Xiang; L. Gore; M. Beeram; R. Brachmann; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Phase 1 and dose-finding study of patrit

Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors

✍ Wakui, Hiroshi; Yamamoto, Noboru; Nakamichi, Shinji; Tamura, Yousuke; Nokihara, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 341 KB